"Context--The Women's Health Initiative (WHI) trial of estrogen plus progestin vs. placebo was stopped early, after a mean 5.6 years of follow-up, because the overall health risks of hormone therapy exceeded its benefits.

"Objective--To report health outcomes at 3 years...after the intervention was stopped...

"Conclusions--...A greater risk of fatal and nonfatal malignancies occurred after intervention in the (treatment group)"

Emphases added.

From: Journal of the A.M.A., vol. 299, 2008. By: Drs. Heiss, Wallace, Stefanick, et al, U. of N. Carolina, U. of Iowa, Fred Hutchinson Cancer Res. Ctr., U. of Texas Health Science Ctr., Harbor-UCLA Med. Ctr., U. of Cinn., Brigham & Women's Hosp., Harvard Med. School, Nat'l. Heart, Lung, and Blood Inst., and Stanford Prevention Res. Ctr.

Our editor's comment, "Soy beans, anyone?"

back to Women's Health index

back to Men's Health index

TOP OF PAGE

SEARCH BY SUBJECT - TABLE OF CONTENTS

THIS MONTH'S HEALTH BULLETIN NEWS

If you find Health Bulletin interesting, please click here to "Tell a Friend"

click here